MDxHealth is trading 5% down at $0.81, primarily amid broader risk-off sentiment and profit-taking after its recent rally.

  • No new company-specific announcement was identified for August 18, 2026.
  • The Nasdaq Composite fell 1.10% and the S&P 500 dropped 0.53% as technology shares led the retreat.
  • Recent quarterly results included an EPS miss and a $20 million registered direct financing, both announced before August 18.